Showing 1 - 20 results of 3,895 for search '(( c large decrease ) OR ((( 6 ((teer decrease) OR (we decrease)) ) OR ( _ largest decrease ))))', query time: 0.63s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  7. 7

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  8. 8

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  9. 9
  10. 10
  11. 11
  12. 12

    Large Hyperfine Coupling Arising from Pseudo‑<sup>2</sup>S Ground States in a Series of Lutetium(II) Metallocene Complexes by Danh X. Ngo (6110606)

    Published 2025
    “…To our knowledge, this degree of s-character in a molecular orbital is the largest yet reported for an open-shell isolable complex. …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Overview of the WeARTolerance program. by Ana Beato (20489933)

    Published 2024
    “…This research evaluates the "WeARTolerance’’ arts-based program in reducing mental health stigma among diverse youths. …”
  18. 18
  19. 19

    Image 6_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

    Published 2025
    “…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.…”
  20. 20